Self-assembled metal–phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy-Reference-Cited by-同舟云学术

Self-assembled metal–phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy

Published:2024 Issue:14 Volume:12 Page:3649-3658
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Zhang Xingzu¹,Zong Qingyu¹,Lin Taian²,Ullah Ihsan²,Jiang Maolin²,Chen Siyi³,Tang Wenjie³,Guo Yuan³,Yuan Youyong²⁴^ORCID,Du Jinzhi¹⁴^ORCID

Affiliation:

1. School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China

2. School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P.R. China

3. Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, P.R. China

4. National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, P.R. China

Abstract

Despite cisplatin's pivotal role in clinically proven anticancer drugs, its application has been hampered by severe side effects and a grim prognosis.

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00650J

Reference39 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Bio-inspired, bioengineered and biomimetic drug delivery carriers

3. Hypochlorous Acid Promoted Platinum Drug Chemotherapy by Myeloperoxidase-Encapsulated Therapeutic Metal Phenolic Nanoparticles

4. Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma

5. Parkin regulates kainate receptors by interacting with the GluK2 subunit